Ethical Considerations for Treating Cancer Patients During the SARS-CoV-2 Virus Crisis: To Treat or Not to Treat? A Literature Review and Perspective From a Cancer Center in Low-Middle Income Country

Providing routine healthcare to patients with serious health illnesses represents a challenge to healthcare providers amid the SARS-CoV-2 pandemic. Treating cancer patients during this pandemic is even more complex due to their heightened vulnerability, as both cancer and cancer treatment weaken the...

Full description

Bibliographic Details
Main Authors: Amal Al-Tabba', Maysa Al-Hussaini, Razan Mansour, Hala Sultan, Hikmat Abdel-Razeq, Asem Mansour
Format: Article
Language:English
Published: Frontiers Media S.A. 2020-10-01
Series:Frontiers in Medicine
Subjects:
Online Access:https://www.frontiersin.org/article/10.3389/fmed.2020.561168/full
id doaj-0adbdd87d6db4356939a5a2dd60f5a46
record_format Article
spelling doaj-0adbdd87d6db4356939a5a2dd60f5a462020-11-25T02:19:30ZengFrontiers Media S.A.Frontiers in Medicine2296-858X2020-10-01710.3389/fmed.2020.561168561168Ethical Considerations for Treating Cancer Patients During the SARS-CoV-2 Virus Crisis: To Treat or Not to Treat? A Literature Review and Perspective From a Cancer Center in Low-Middle Income CountryAmal Al-Tabba'0Maysa Al-Hussaini1Maysa Al-Hussaini2Razan Mansour3Hala Sultan4Hikmat Abdel-Razeq5Hikmat Abdel-Razeq6Asem Mansour7Asem Mansour8Independent Researcher, Amman, JordanDepartment of Pathology and Laboratory Medicine, King Hussein Cancer Center, Amman, JordanHuman Research Participants Protection Office, King Hussein Cancer Center, Amman, JordanOffice of Scientific Affairs and Research, King Hussein Cancer Center, Amman, JordanUniversity of Jordan School of Medicine, Amman, JordanUniversity of Jordan School of Medicine, Amman, JordanDepartment of Medical Oncology, King Hussein Cancer Center, Amman, JordanHuman Research Participants Protection Office, King Hussein Cancer Center, Amman, JordanKing Hussein Cancer Center, Amman, JordanProviding routine healthcare to patients with serious health illnesses represents a challenge to healthcare providers amid the SARS-CoV-2 pandemic. Treating cancer patients during this pandemic is even more complex due to their heightened vulnerability, as both cancer and cancer treatment weaken the immune system leading to a higher risk of both infections and severe complications. In addition to the need to protect cancer patients from unnecessary exposure to SARS-CoV-2 infection during their routine care, interruption, and discontinuation of cancer treatment can result in negative consequences on patients' health, in addition to the ghost of rationing healthcare resources in high demand during a global health crisis. This article aims to explore the ethical dilemmas faced by decision-makers and healthcare providers caring for cancer patients during the SARS-CoV-2 pandemic. This includes setting triage criteria for non-infected cancer patients, fairly allocating limited healthcare resources between cancer patients and SARS-CoV-2 patients, prioritizing SARS-CoV-2 treatment or vaccine, once developed, for cancer patients and non-cancer patients, patient-physician communication on matters such as end-of-life and do-not-resuscitate (DNR), and lastly, shifting physicians' priorities from treating their own cancer patients to treating critically ill SARS-CoV-2 infected patients. Ultimately, no straightforward decision can be easily made at such exceptionally difficult times. Applying different ethical principles can result in very different scenarios and consequences. In the end, we will briefly share the experience of the King Hussein Cancer Center (KHCC), the only standalone comprehensive cancer center in the region.https://www.frontiersin.org/article/10.3389/fmed.2020.561168/fullpandemicethicscancer careguidelinesSARS-CoV-2COVID-19
collection DOAJ
language English
format Article
sources DOAJ
author Amal Al-Tabba'
Maysa Al-Hussaini
Maysa Al-Hussaini
Razan Mansour
Hala Sultan
Hikmat Abdel-Razeq
Hikmat Abdel-Razeq
Asem Mansour
Asem Mansour
spellingShingle Amal Al-Tabba'
Maysa Al-Hussaini
Maysa Al-Hussaini
Razan Mansour
Hala Sultan
Hikmat Abdel-Razeq
Hikmat Abdel-Razeq
Asem Mansour
Asem Mansour
Ethical Considerations for Treating Cancer Patients During the SARS-CoV-2 Virus Crisis: To Treat or Not to Treat? A Literature Review and Perspective From a Cancer Center in Low-Middle Income Country
Frontiers in Medicine
pandemic
ethics
cancer care
guidelines
SARS-CoV-2
COVID-19
author_facet Amal Al-Tabba'
Maysa Al-Hussaini
Maysa Al-Hussaini
Razan Mansour
Hala Sultan
Hikmat Abdel-Razeq
Hikmat Abdel-Razeq
Asem Mansour
Asem Mansour
author_sort Amal Al-Tabba'
title Ethical Considerations for Treating Cancer Patients During the SARS-CoV-2 Virus Crisis: To Treat or Not to Treat? A Literature Review and Perspective From a Cancer Center in Low-Middle Income Country
title_short Ethical Considerations for Treating Cancer Patients During the SARS-CoV-2 Virus Crisis: To Treat or Not to Treat? A Literature Review and Perspective From a Cancer Center in Low-Middle Income Country
title_full Ethical Considerations for Treating Cancer Patients During the SARS-CoV-2 Virus Crisis: To Treat or Not to Treat? A Literature Review and Perspective From a Cancer Center in Low-Middle Income Country
title_fullStr Ethical Considerations for Treating Cancer Patients During the SARS-CoV-2 Virus Crisis: To Treat or Not to Treat? A Literature Review and Perspective From a Cancer Center in Low-Middle Income Country
title_full_unstemmed Ethical Considerations for Treating Cancer Patients During the SARS-CoV-2 Virus Crisis: To Treat or Not to Treat? A Literature Review and Perspective From a Cancer Center in Low-Middle Income Country
title_sort ethical considerations for treating cancer patients during the sars-cov-2 virus crisis: to treat or not to treat? a literature review and perspective from a cancer center in low-middle income country
publisher Frontiers Media S.A.
series Frontiers in Medicine
issn 2296-858X
publishDate 2020-10-01
description Providing routine healthcare to patients with serious health illnesses represents a challenge to healthcare providers amid the SARS-CoV-2 pandemic. Treating cancer patients during this pandemic is even more complex due to their heightened vulnerability, as both cancer and cancer treatment weaken the immune system leading to a higher risk of both infections and severe complications. In addition to the need to protect cancer patients from unnecessary exposure to SARS-CoV-2 infection during their routine care, interruption, and discontinuation of cancer treatment can result in negative consequences on patients' health, in addition to the ghost of rationing healthcare resources in high demand during a global health crisis. This article aims to explore the ethical dilemmas faced by decision-makers and healthcare providers caring for cancer patients during the SARS-CoV-2 pandemic. This includes setting triage criteria for non-infected cancer patients, fairly allocating limited healthcare resources between cancer patients and SARS-CoV-2 patients, prioritizing SARS-CoV-2 treatment or vaccine, once developed, for cancer patients and non-cancer patients, patient-physician communication on matters such as end-of-life and do-not-resuscitate (DNR), and lastly, shifting physicians' priorities from treating their own cancer patients to treating critically ill SARS-CoV-2 infected patients. Ultimately, no straightforward decision can be easily made at such exceptionally difficult times. Applying different ethical principles can result in very different scenarios and consequences. In the end, we will briefly share the experience of the King Hussein Cancer Center (KHCC), the only standalone comprehensive cancer center in the region.
topic pandemic
ethics
cancer care
guidelines
SARS-CoV-2
COVID-19
url https://www.frontiersin.org/article/10.3389/fmed.2020.561168/full
work_keys_str_mv AT amalaltabba ethicalconsiderationsfortreatingcancerpatientsduringthesarscov2viruscrisistotreatornottotreataliteraturereviewandperspectivefromacancercenterinlowmiddleincomecountry
AT maysaalhussaini ethicalconsiderationsfortreatingcancerpatientsduringthesarscov2viruscrisistotreatornottotreataliteraturereviewandperspectivefromacancercenterinlowmiddleincomecountry
AT maysaalhussaini ethicalconsiderationsfortreatingcancerpatientsduringthesarscov2viruscrisistotreatornottotreataliteraturereviewandperspectivefromacancercenterinlowmiddleincomecountry
AT razanmansour ethicalconsiderationsfortreatingcancerpatientsduringthesarscov2viruscrisistotreatornottotreataliteraturereviewandperspectivefromacancercenterinlowmiddleincomecountry
AT halasultan ethicalconsiderationsfortreatingcancerpatientsduringthesarscov2viruscrisistotreatornottotreataliteraturereviewandperspectivefromacancercenterinlowmiddleincomecountry
AT hikmatabdelrazeq ethicalconsiderationsfortreatingcancerpatientsduringthesarscov2viruscrisistotreatornottotreataliteraturereviewandperspectivefromacancercenterinlowmiddleincomecountry
AT hikmatabdelrazeq ethicalconsiderationsfortreatingcancerpatientsduringthesarscov2viruscrisistotreatornottotreataliteraturereviewandperspectivefromacancercenterinlowmiddleincomecountry
AT asemmansour ethicalconsiderationsfortreatingcancerpatientsduringthesarscov2viruscrisistotreatornottotreataliteraturereviewandperspectivefromacancercenterinlowmiddleincomecountry
AT asemmansour ethicalconsiderationsfortreatingcancerpatientsduringthesarscov2viruscrisistotreatornottotreataliteraturereviewandperspectivefromacancercenterinlowmiddleincomecountry
_version_ 1724876436064436224